BBP : Virtus LifeSci Biotech Products ETF

BBP is a Sector Equity Market Healthcare with MODERATE fees.

BBP

Virtus LifeSci Biotech Products ETF

FI Score

38 /100

Diversification Rating

10 /10

Expense Ratio Rating

6 /10

Expense Rating

2 /10

Market Score

1 /10

Category Score

0 /10

Market Size

1 /10

38% FI Score
  • bbp
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Products ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.

Largest Holdings

Amount Holding
4.14% Acceleron Pharma Inc
3.98% Momenta Pharmaceuticals, Inc
3.45% Regeneron Pharmaceuticals, Inc
3.39% Ultragenyx Pharmaceutical Inc
2.93% Exelixis, Inc
2.92% Seattle Genetics, Inc
2.81% BioMarin Pharmaceutical Inc
2.80% Amicus Therapeutics, Inc
2.78% United Therapeutics Corporation
2.77% Vertex Pharmaceuticals Incorporated

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo